| Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents | 04/08/2025 | |
| Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors | 04/09/2025 | |
| HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps | 04/09/2025 | |
| Significance of HER2 Expression in Solid Tumors | 04/09/2025 | |
| Expanding Horizons: HER2 Targeting in Metastatic Solid Tumors | | |
| Chemotherapy Strategies for Metastatic PDAC | 04/10/2025 | |
| Diagnosis and Management of Metastatic PDAC | 04/08/2025 | |
| Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Diagnosis to Treatment | | |
